Correlation Between Windtree Therapeutics and ZyVersa Therapeutics

Can any of the company-specific risk be diversified away by investing in both Windtree Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Windtree Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Windtree Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Windtree Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Windtree Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Windtree Therapeutics and ZyVersa Therapeutics.

Diversification Opportunities for Windtree Therapeutics and ZyVersa Therapeutics

-0.59

Correlation Coefficient

Windtree Therapeutics  ZyVersa Therapeutics

Excellent diversification

The 3 months correlation between Windtree and ZyVersa is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Windtree Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Windtree Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Windtree Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Windtree Therapeutics i.e., Windtree Therapeutics and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Windtree Therapeutics and ZyVersa Therapeutics

Given the investment horizon of 90 days Windtree Therapeutics is expected to under-perform the ZyVersa Therapeutics. In addition to that, Windtree Therapeutics is 1.19 times more volatile than ZyVersa Therapeutics. It trades about -0.43 of its total potential returns per unit of risk. ZyVersa Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest  107.00  in ZyVersa Therapeutics on November 28, 2024 and sell it today you would earn a total of  5.00  from holding ZyVersa Therapeutics or generate 4.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Windtree Therapeutics  vs.  ZyVersa Therapeutics

Windtree Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Windtree Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

ZyVersa Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ZyVersa Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ZyVersa Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Windtree Therapeutics and ZyVersa Therapeutics

The main advantage of trading using opposite Windtree Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Windtree Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.

The idea behind Windtree Therapeutics and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.